ストックスクリーナーアプリを入手
8.40
3.11%
-0.27
前日終値:
$8.67
開ける：
$8.68
24時間の取引高:
807.74K
Relative Volume:
0.63
時価総額：
$659.00M
収益：
$400.05M
当期純損益:
$181.01M
株価収益率:
4.0013
EPS:
2.0993
ネットキャッシュフロー:
$194.71M
1週間 パフォーマンス:
-4.00%
1か月 パフォーマンス:
-4.22%
6か月 パフォーマンス:
+10.09%
1年 パフォーマンス:
-28.27%
1日の値動き範囲:
$8.22
$8.72
1週間の範囲:
$8.22
$8.98
52週間の値動き範囲:
$6.125
$14.96
CorMedix Inc Stock (CRMD) Company Profile
名前
CorMedix Inc
セクター
電話
908-517-9500
住所
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
8.40 | 659.00M | 400.05M | 181.01M | 194.71M | 2.0993 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-20 | アップグレード | D. Boral Capital | Hold → Buy |
| 2025-06-30 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2025-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2025-03-07 | 開始されました | Leerink Partners | Outperform |
| 2025-01-13 | 開始されました | D. Boral Capital | Buy |
| 2024-08-26 | 開始されました | Rodman & Renshaw | Buy |
| 2023-08-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-02-17 | 開始されました | Needham | Buy |
| 2020-09-29 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-09-21 | 開始されました | Truist | Buy |
| 2019-12-18 | 開始されました | B. Riley FBR | Buy |
| 2019-03-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-12-06 | 開始されました | ROTH Capital | Buy |
| 2017-09-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-08-10 | 繰り返されました | Rodman & Renshaw | Buy |
| 2017-05-05 | 繰り返されました | Rodman & Renshaw | Buy |
| 2016-11-11 | 繰り返されました | FBR & Co. | Outperform |
| 2016-03-17 | 繰り返されました | FBR Capital | Outperform |
| 2016-03-03 | 開始されました | FBR Capital | Outperform |
| 2015-11-16 | 繰り返されました | ROTH Capital | Neutral |
| 2015-10-29 | 繰り返されました | ROTH Capital | Neutral |
| 2015-05-06 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 繰り返されました | ROTH Capital | Buy |
| 2011-10-03 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
CorMedix Inc (CRMD) 最新ニュース
Private Advisor Group LLC Buys 126,131 Shares of CorMedix Inc $CRMD - MarketBeat
RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13 - Moomoo
RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating - marketscreener.com
CRMDCorMedix Inc Volatility & Greeks - Finviz
CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits
Cormedix Restructures Leadership, Expands Operating and Commercial Role - The Globe and Mail
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer - Moomoo
[8-K] CorMedix Inc. Reports Material Event - Stock Titan
Lobbying Update: $380,000 of CORMEDIX INC. lobbying was just disclosed - Quiver Quantitative
Tranche Update on CorMedix Inc.'s Equity Buyback Plan announced on February 2, 2026. - marketscreener.com
Liquidity Mapping Around (CRMD) Price Events - Stock Traders Daily
CRMD,PEP Revenue Breakdown - Finviz
CORMEDIX INC. Files 8-K: Company Details, Stock Info & SEC Filing Summary for June 25, 2026 - Minichart
CorMedix (NASDAQ: CRMD) replaces CBIZ with Ernst & Young as auditor - Stock Titan
CRMD's Growth Story Expands Beyond DefenCath Into New Trends - Yahoo Finance
Is CRMD Stock a Buy Now After Strong Growth and New Risks? - Yahoo Finance
CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path - TradingView
CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2500 Growth Benchmark - marketscreener.com
CorMedix Inc. (CRMD) Slips 2.74% as Stock Tests Support Near $7.25Volatility Smirk - dars.gov.et
CorMedix Inc.(NasdaqGM: CRMD) added to Russell 2000 Value Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) added to Russell Microcap Value Benchmark Index - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2000 Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Why Did CRMD Stock Tumble Over 11% Today? - Stocktwits
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to EBIT forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Price to book forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Price to sales forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Is Now The Time To Put CorMedix (NASDAQ:CRMD) On Your Watchlist? - Moomoo
Price to earnings forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Enterprise value to EBITDA forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Form DEF 14A CorMedix Inc For: 25 June - Investing.com UK
Form DEF 14A CorMedix Inc For: 25 June By Investing.com - Investing.com Australia
CorMedix Inc. Actuals & Estimates (NASDAQ:CRMD) - TradingView
CRMD Forecast — Price Target — Prediction for 2027 - TradingView
CorMedix Shareholders Reject Governance Changes at Annual Meeting - The Globe and Mail
CorMedix (CRMD) shareholders affirm directors but vote down multiple charter amendments - Stock Titan
CorMedix Inc (CRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why (CRMD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Raised 2026 Guidance and DefenCath Momentum Might Change The Case For Investing In CorMedix (CRMD) - simplywall.st
CorMedix Inc (CRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CorMedix Inc. (CRMD) Achieves Remarkable 384.60% Revenue Growth - GuruFocus
CorMedix Inc (CRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CorMedix Inc (CRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CorMedix Inc (CRMD) Institutional Confidence - TradingKey
CorMedix Inc (CRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CorMedix Inc (CRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CorMedix Inc (CRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CorMedix Inc (CRMD) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
大文字化:
|
ボリューム (24 時間):